About US
Contact us
-
FDA to Discuss Part 11 Inspection Assignment at ISPE WashingtonCDER will begin a human drug inspectional initiative (TAMPA, FLORIDA, USA, 4 June 2010) – ISPE, a global not-for-profit association of 24,000 pharmaceutical science and manufacturing professiona2010/6/8
-
All New DiscoveryGate from Symyx Now Provides Online Access to “Gold Standard” of Chemical SourcingNew Web-portal accelerates compound sourcing, saves time, and reduces cost with access to more than 890 chemical suppliers Symyx Technologies, Inc. (NASDAQ: SMMX) today announced the release of All2010/6/7
-
Pacific Edge Announces Successful Completion of Colorectal Cancer Prognostic Clinical TrialCHICAGO--(BUSINESS WIRE)-- Pacific Edge (PEB), a New Zealand-based biomedical company, today announced the successful completion of the European clinical trial for their prognostic gene signature fo2010/6/7
-
ACG North America Introduces AF-200(T) Automatic Capsule Filling MachineACG North America introduces the latest in its AF Series of Capsule Filling machines, the AF-200(T). The AF-200(T) offers one of the fastest encapsulation speeds available, filling up to 200,000 capsu2010/6/7
-
Contents of a Complete Submission for the Evaluation of Proprietary Names20100604.rar2010/6/4
-
Document Standard for Law Enforcement on Food Safety Supervision in Catering Services issuedIn order to carry out the Provisions for Catering Services Licensing and the Provisions for Food Safety Supervision in Catering Services, and formalize the law enforcement on catering services2010/6/4
-
SFDA and the Ministry of Health to take further actions to curb non-drug substance being simulated as drugIn order to crack down on the illegal activities of non-drug substance being simulated as drug and safeguard the public’s health, recently, the State Food and Drug Administration (SFDA) and th2010/6/4
-
Orexigen® Therapeutics Announces FDA Acceptance Of Contrave® New Drug Application For The Treatment Of ObesitySan Diego/PRNewswire-FirstCall/ -- Orexigen® Therapeutics, Inc. (Nasdaq: OREX), a biopharmaceutical company focused on the treatment of obesity, today announced that the U.S. Food and Drug Adminis2010/6/3
-
Extension Study With FIRMAGON® (degarelix) Showed Continued Benefits For Prostate Cancer Patients Beyond One YearANNOUNCED AT LEADING UROLOGY MEETING San Francisco/PRNewswire/ -- Prostate cancer patients on leuprolide who were offered to continue on FIRMAGON® (degarelix for injection) after one year of trea2010/6/3
-
SBS Biomolecular Screening SymposiumSBS Biomolecular Screening SymposiumAdvanced Applications Across Academia, Government & IndustryOctober 18 -19, 2010 - Sheraton Imperial Hotel & Convention CenterDurham, NC, USAwww.sbsonline.o2010/6/3